Search

Your search keyword '"SPADARO G"' showing total 62 results

Search Constraints

Start Over You searched for: Author "SPADARO G" Remove constraint Author: "SPADARO G" Topic medicine Remove constraint Topic: medicine
62 results on '"SPADARO G"'

Search Results

1. Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry

2. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry

3. Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry

4. COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments

5. Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?

6. Frequency of tiotropium bromide use and clinical features of patients with severe asthma in a real-life setting: Data from the severe asthma network in Italy (sani) registry

7. Characteristics and treatment regimens across ERS SHARP severe asthma registries

8. Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI

9. Clinical features and follow-up in patients with 22q11.2 deletion syndrome

10. Corrigendum to: 'Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET)' [Vaccine 36 (2018) Pages 3541–3542]

11. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study

12. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency

13. Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis

14. Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression

15. Severe asthma: One disease and multiple definitions

16. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

17. The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019)

18. Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study

19. Psychological processes in the experience of hereditary angioedema in adult patients: an observational study

20. Immunoglobulins G modulate endothelial function and affect insulin sensitivity in humans

21. Angiotensin-Converting Enzyme Inhibitor– Associated Angioedema: From Bed to Bench

22. Clinical features and burden of genital attacks in hereditary angioedema

23. Relationship between the Clinical Frailty Scale and short-term mortality in patients ≥ 80 years old acutely admitted to the ICU: a prospective cohort study

24. Immunosuppressive therapy with rituximab in common variable immunodeficiency

25. Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity

26. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

27. Orofacial granulomatosis: Clinical and therapeutic features in an Italian cohort and review of the literature

28. Common Variable Immunodeficiency and Autoimmune Diseases: A Retrospective Study of 95 Adult Patients in a Single Tertiary Care Center

29. Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series

30. Episodic angioedema with hypereosinophilia (Gleich’s syndrome): A case report and extensive review of the literature

31. Roles of Immune Cells in Hereditary Angioedema

32. Psychology and hereditary angioedema: A systematic review

33. Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors

34. Nailfold videocapillaroscopy findings in bradykinin-mediated angioedema

35. Gastrointestinal manifestations of angioedema: A potential area of misdiagnosis

36. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study

37. Respiratory Manifestations in Primary Immunodeficiencies: Findings From a Pediatric and Adult Cohort

38. The immunology of switching biologics in severe eosinophilic asthma patients

39. Differently expressed microRNA in response to the first Ig replacement therapy in common variable immunodeficiency patients

40. Role of Endothelial G Protein-Coupled Receptor Kinase-2 in Angioedema

41. Heterogeneity of Liver Disease in Common Variable Immunodeficiency Disorders

42. Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality

43. Macrophage-polarizing stimuli differentially modulate the inflammatory profile induced by the secreted phospholipase A2 group IA in human lung macrophages

44. Desensitization of two young patients with infantile-onset Pompe disease and severe reactions to alglucosidase alfa

45. Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthma

46. Ultrasound-based transient elastography improves the detection of liver disease in common variable immunodeficiency

47. Psoriasis in a cohort of patients with common variable immunodeficiency

48. Innate immune modulation by GM-CSF and IL-3 in health and disease

49. Adiponectin Receptors and Pro-inflammatory Cytokines Are Modulated in Common Variable Immunodeficiency Patients: Correlation With Ig Replacement Therapy

50. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience

Catalog

Books, media, physical & digital resources